Blog

$Mulham Ombada: Difficult Case of a Severe Refractory ITP$

Mulham Ombada/X

Oct 13, 2024, 15:04

Mulham Ombada: Difficult Case of a Severe Refractory ITP

Mulham Ombada, Internal Medicine Residency at Upstate Medical University, shared a post on X:

“Excited to share that our new abstract “Struck by Tsunami: Difficult Case of a Severe Refractory ITP” got approved for publication at Blood Journal.

Grateful for the tremendous support by my mentor Dr. Teresa Gentile and all collaborators.”

Blood Journal cancer James B. Bussel Ming Hou Mulham Ombada OncoDaily Oncology Oriana Miltiadous Teresa Gentile Tsunami: Upstate Medical University

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Science

Feb 22, 2025, 16:00

Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM

Blog

Feb 22, 2025, 15:54

Patrick Forde: Great day for lung cancer care

Science

Feb 22, 2025, 15:48

Shankar Siva: Whats new in stage IV cancer?

Science

Feb 22, 2025, 15:33

Updated ESMO Clinical Practice Guideline on Hepatocellular Carcinoma

Science

Feb 22, 2025, 15:14

Erman Akkus: Stage specific characterization of early-onset colorectal cancer

Blog

Feb 22, 2025, 15:04

John Gordon: Successful CAR Tcell Therapy - "It's a Bug's Life"

Blog

Feb 22, 2025, 14:43

Giannis Mountzios: How active ADCs against oncogene-addicted NSCLC?

Science

Feb 22, 2025, 14:10

Yan Leyfman: Advancing CAR T-Cell Therapy - Off-the-Shelf Allogeneic Approach

Science

Feb 22, 2025, 13:28

Elvina Almuradova: Immunotherapy for HPV-Associated Cancers

Opinion

Feb 22, 2025, 13:10

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

Science

Feb 22, 2025, 13:10

Why immunotherapy has struggled in EGFR+ lung cancer - EGFR Positive Lung Cancer UK

Blog

Feb 22, 2025, 13:04

Debate session on the management of stage III NSCLC in the IO era - ESTRO